ArticleTechnology in cancer research & treatment2019

miR-206 Promotes Cancer Progression by Targeting Full-Length Neurokinin-1 Receptor in Breast Cancer.

Yu Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.